Drug Trial Radar · NCT07409181
A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
405
Planned (sponsor's estimate)
Start
Apr 20, 2026
Primary completion
Feb 4, 2029
Study completion Jul 8, 2029
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Feb 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 74 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is open to adults with systemic lupus erythematosus (SLE). The purpose of this study is to find out whether a medicine called BI 3000202 helps people with SLE. The study tests different doses of BI 3000202 and aims to find the best dose for people with this condition. Participants are put into 5 groups randomly, which means by chance. 4 groups get different doses of BI 3000202, and 1 group gets a placebo. Placebo tablets look like BI 3000202 tablets but do not contain any medicine. Participants take the tablets for 1 year. All participants also continue their regular treatment for SLE. Participants are in the study for a bit longer than 1 year. During this time, they visit the study site regularly. Doctors check the participants' health and take note of any unwanted effects. They also compare the results between the groups to see if the treatment works.
Conditions
- Systemic Lupus Erythematosus
Interventions
BI 3000202Drug
BI 3000202 at different doses
PlaceboDrug
Placebo matching BI 3000202
Primary outcomes
What the sponsor says the trial is designed to measure.
- Achievement of a Systemic Lupus Erythematosus Responder Index (SRI)-4 responseTime frame: At Week 32
Locations
139 sites in 21 countries. Site status is shown where the registry gives one.
Wallace & Lee Center
Beverly Hills, California · Not yet recruiting
Arthritis & Osteoporosis Medical Center, Inc - La Palma
La Palma, California · Recruiting
University of California San Diego
San Diego, California · Not yet recruiting
University of California Los Angeles
Torrance, California · Recruiting
Inland Rheumatology Clinical Trials, Inc
Upland, California · Recruiting
Focus Clinical Research
West Hills, California · Recruiting
Denver Arthritis Clinic - Lowry
Denver, Colorado · Not yet recruiting
AARDS Research, Inc.
Aventura, Florida · Recruiting
Meris Clinical Research-Brandon-69466
Brandon, Florida · Not yet recruiting
Clinical Research of West Florida, Inc.
Clearwater, Florida · Not yet recruiting
Integral Rheumatology and Immunology Specialist
Plantation, Florida · Not yet recruiting
Clinical Research of West Florida, Inc. - Tampa
Tampa, Florida · Recruiting
AA MRC LLC - Grand Blanc
Grand Blanc, Michigan · Not yet recruiting
June DO, PC
Lansing, Michigan · Not yet recruiting
Oscar Clinical Trials
Jackson, Mississippi · Recruiting
Boeson Research - Great Falls
Great Falls, Montana · Recruiting
DJL Clinical Research, PLLC
Charlotte, North Carolina · Not yet recruiting
Cross Creek Medical Clinic, PA
Fayetteville, North Carolina · Recruiting
Paramount Medical Research and Consulting
Middleburg Heights, Ohio · Recruiting
Oklahoma Medical Research Foundation
Oklahoma City, Oklahoma · Recruiting
Altoona Arthritis & Osteoporosis Center - Altoona Center for Clinical Research
Duncansville, Pennsylvania · Recruiting
West Tennessee Research Institute
Jackson, Tennessee · Not yet recruiting
Shelby Research LLC
Memphis, Tennessee · Recruiting
Amarillo Center for Clinical Research
Amarillo, Texas · Recruiting
Precision Comprehensive Clinical Research Solutions - Colleyville
Colleyville, Texas · Recruiting
Precision Comprehensive Clinical Research Solutions
Euless, Texas · Recruiting
Arthritis & Rheumatology Institute - Frisco
Frisco, Texas · Recruiting
The University of Texas Health Science Center at Houston
Houston, Texas · Not yet recruiting
R&H Clinical Research - Katy
Katy, Texas · Recruiting
SouthWest Rheumatology Research
Mesquite, Texas · Not yet recruiting
Centro Medico Reumatologico - OMI
CABA, Argentina · Recruiting
Instituto de Investigacion Clinica TyT
CABA, Argentina · Recruiting
Instituto Medico Especializado
Capital Federal, Argentina · Recruiting
Consultora integral en Salud SRL.
General Paz, Argentina · Recruiting
Sanatorio Maipu
Maipu, Argentina · Recruiting
Instituto de Investigaciones Clinicas Quilmes
Quilmes, Argentina · Recruiting
Centro de Investigaciones Medicas Tucuman
San Miguel de Tucumán, Argentina · Recruiting
Austin Health
Heidelberg, Victoria, Australia · Recruiting
Fiona Stanley Hospital
Murdoch, Western Australia, Australia · Recruiting
SAPIENS - Instituto de Estudos e Pesquisa Clinica
Curitiba, Brazil · Recruiting
Showing 40 of 139 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.